Advances in Cardiovascular Engineering

  • Ned H. C. Hwang
  • Vincent T. Turitto
  • Michael R. T. Yen

Part of the NATO ASI Series book series (NSSA, volume 235)

Table of contents

  1. Front Matter
    Pages i-viii
  2. Benjamin W. Zweifach
    Pages 1-6
  3. Benjamin W. Zweifach
    Pages 7-24
  4. Robert S. Reneman, Bea Woldhuis, Mirjam G. A. oude Egbrink, Dick W. Slaaf, Geert Jan Tangelder
    Pages 25-40
  5. Steven M. Slack, Winnie Cui, Vincent T. Turitto
    Pages 91-102
  6. Gordon D. O. Lowe
    Pages 103-107
  7. Harry L. Goldsmith, Takeshi Karino
    Pages 127-150
  8. Kjell S. Sakariassen, Helge E. Roald, José Aznar Salatti
    Pages 151-174
  9. Shi-Kang Wang, Ned H. C. Hwang
    Pages 259-298
  10. Klaus Affeld, Klaus Schichl, Andreas Ziemann
    Pages 299-324
  11. Manuel Concha, Manuel Anguita, Anastasio Montero, José M. Arizón, Federico Vallés, José M. Latre et al.
    Pages 325-343
  12. Jean-Raoul Monties, Patrick Havlik, Thierry Mesana
    Pages 345-361
  13. Peter P. McKeown, Stephen G. Kovacs
    Pages 363-384
  14. Travis J. Phifer, Ned H. C. Hwang
    Pages 385-415
  15. Back Matter
    Pages 435-443

About this book


Advances of cardiovascular engineering prompt one to consider innovative device technology - that is, the development of new replacement heart valves or engineering of a totally implantable energy source for an artificial heart. However, these kinds of advances have often proved unable to achieve a long-lasting benefit as the cardiovascular field has matured so fast. Cardiovascular engineering has matured to the point where a major innovation must not only function, but must continuously function better than existing devices. This is difficult to accomplish in the complex cardiovasculature system, in which energy source, biocompatibility, compliance, and functionality all must be considered. The maturation of the field is evident from the fact that many engineered prosthetic systems perform well - for example, heart valves function for long periods of time, large-vessel vascular grafts are quite adequate, extracorporeal membrane oxygenation has significantly prolonged the feasible length of heart bypass and other surgical operations, and total artificial hearts can be used as a bridge to transplant without serious complications, yet none of these systems is as good as the natural ones it replaces. The reasons for this are many and incompletely understood. The next stage of progress must be better to alterations understandings of the various components of vasculature and their response by our devices, be they at the micro- or macro-circulatory levels, in the blood, or associated with the vascular wall.


biomaterial blood cell bypass cardiovascular circulation complications growth heart implant thrombosis tissue

Editors and affiliations

  • Ned H. C. Hwang
    • 1
  • Vincent T. Turitto
    • 2
  • Michael R. T. Yen
    • 2
  1. 1.University of MiamiCoral GablesUSA
  2. 2.Department of Biomedical EngineeringMemphis State UniversityMemphisUSA

Bibliographic information